Citafine 1400mg Injection 1’S

Description

Citafine 1400mg Injection is a prescription anticancer medicine used in the treatment of several types of cancer. it belongs to a class of medicines known as antimetabolites, specifically a nucleoside analog. in simple terms, it works by interfering with the way cancer cells make and repair their dna. because rapidly growing cancer cells need to copy their dna in order to multiply, Citafine 1400mg Injection can slow down or stop their growth. this makes it an important option in oncology, often used when a cancer is advanced, metastatic, or needs combination treatment.

Citafine 1400mg Injection is not a cure-all medicine, and it is not suitable for every cancer or every patient. it is commonly used in carefully selected situations by oncologists, often as part of a treatment plan that may include other chemotherapy medicines, radiation in some settings, or surgery depending on the type and stage of cancer. the exact use depends on the cancer being treated, the patient’s overall health, blood counts, liver and kidney function, and how well previous treatments have worked. because it can affect normal rapidly dividing cells as well, it may cause side effects such as lowered blood counts, fatigue, nausea, and increased risk of infection.

mechanistically, Citafine 1400mg Injection enters cells and is converted into active forms that disrupt dna synthesis. cancer cells tend to divide faster than most healthy cells, so they are more vulnerable to this effect. the medicine can also reduce the ability of the cancer cell to repair dna damage, increasing cell death. this dual action is one reason it is widely used in oncology. however, because normal cells in the bone marrow, digestive tract, skin, and hair follicles also divide quickly, some healthy tissues can be affected too, which explains many of the common side effects seen with treatment.

this medicine is generally administered by healthcare professionals, usually as an intravenous infusion in a hospital, infusion center, or clinic setting. patients are monitored closely during treatment to track blood counts and organ function. since Citafine 1400mg Injection can be potent and has important safety considerations, it should only be used under supervision of an oncologist or other qualified specialist familiar with chemotherapy management.

ingredients

• Citafine 1400mg Injection: this is the active anticancer ingredient. it acts as a nucleoside analog that interferes with dna synthesis in rapidly dividing cells, helping to slow or stop cancer growth. its benefit is greatest in cancers that rely on fast cellular replication, and it is often used in combination treatment plans.
• inactive ingredients/excipients: depending on the manufacturer and formulation, the product may contain stabilizers, buffering agents, and solvent or formulation components that help maintain the medicine’s potency and allow it to be prepared for infusion. these ingredients do not treat cancer directly, but they are important for product stability, delivery, and safe administration.
• water for injection or reconstitution components: in injectable formulations, sterile water or other approved diluents may be used during preparation by healthcare professionals. these are not therapeutic ingredients, but they are necessary for correct infusion preparation.

key uses

• pancreatic cancer: Citafine 1400mg Injection is commonly used in the treatment of pancreatic cancer, especially when the disease cannot be removed surgically or has spread. it may help slow tumor progression and relieve symptoms in some patients.
• non-small cell lung cancer: it may be used alone or with other chemotherapy medicines in certain patients with advanced or metastatic non-small cell lung cancer. treatment choice depends on cancer stage and the patient’s ability to tolerate chemotherapy.
• breast cancer: in some settings, Citafine 1400mg Injection is part of combination therapy for advanced or metastatic breast cancer, particularly when previous treatments are no longer effective or a broader regimen is needed.
• ovarian cancer: it may be used for recurrent or resistant ovarian cancer in combination with other anticancer agents, helping target disease that has returned or progressed after earlier therapy.
• bladder cancer: Citafine 1400mg Injection is often used with other medicines in advanced bladder cancer, where it may help reduce tumor burden and improve disease control.
• other selected cancers: in some treatment protocols, oncologists may use Citafine 1400mg Injection for other solid tumors based on clinical judgment, prior treatment history, and guideline-supported regimens.

how to use

Citafine 1400mg Injection should be used exactly as directed by an oncology specialist or trained healthcare provider. it is generally given as an intravenous infusion, not taken by mouth. the dose schedule, treatment frequency, and length of therapy vary depending on the type of cancer, the treatment combination, and how the patient responds. before each treatment, blood tests are commonly done to check white blood cells, platelets, hemoglobin, and organ function. this is important because Citafine 1400mg Injection can suppress bone marrow function and affect the body’s ability to fight infection or control bleeding.

the infusion is usually administered in a clinic or hospital setting where the healthcare team can monitor for side effects during and after treatment. patients should inform the medical team about any fever, unusual bruising, bleeding, shortness of breath, severe fatigue, swelling, or signs of infection before receiving a dose. if the medicine is being used in combination with other chemotherapy drugs, the schedule may be adjusted to reduce toxicity while maintaining effectiveness. it is very important not to change the dose, timing, or infusion plan on your own.

because this medicine is part of a specialized cancer treatment plan, patients should follow all instructions given by their oncology team, including hydration advice, infection precautions, and follow-up appointments. if a dose is delayed or omitted due to low blood counts or illness, the medical team will decide when it is safe to continue. self-administration is generally not appropriate unless specifically instructed in a specialized care setting, which is uncommon for this medicine.

safety information

• warnings: Citafine 1400mg Injection can lower blood cell counts, increasing the risk of infection, bleeding, and anemia. it may also affect liver and kidney function, and in rare cases it can cause serious lung problems, severe allergic reactions, blood vessel damage, or a condition called capillary leak syndrome. patients should report fever, cough, shortness of breath, chest pain, jaundice, dark urine, swelling, or unusual bleeding promptly.
• side effects: common side effects include fatigue, nausea, vomiting, loss of appetite, constipation or diarrhea, mild hair thinning, rash, mouth irritation, and flu-like symptoms. more serious side effects can include severe low blood counts, infections, bleeding, allergic infusion reactions, breathing problems, kidney issues, liver injury, and inflammation of the lungs. not all patients experience these effects, but monitoring is essential.
• precautions: use caution in people with liver disease, kidney disease, bone marrow suppression, active infections, respiratory conditions, or poor overall health. patients with a history of radiation therapy may require special monitoring because combined toxicity can occur in some cases. elderly patients may be more vulnerable to side effects and may need closer supervision.
• pregnancy/breastfeeding: Citafine 1400mg Injection may harm an unborn baby and is generally avoided during pregnancy unless the potential benefit clearly outweighs the risk. effective contraception is usually recommended during treatment and for a period afterward as directed by the treating team. breastfeeding is generally not recommended during treatment because the medicine may pass into breast milk and could harm a nursing infant.
• interactions: Citafine 1400mg Injection may interact with other anticancer medicines, medications that suppress bone marrow, and some drugs that affect liver or kidney function. alcohol may worsen fatigue, dehydration, or liver strain and is best avoided or limited unless the doctor says otherwise. always tell the oncology team about all prescription medicines, over-the-counter products, herbal supplements, and vitamins because interaction risk may be significant in cancer treatment.

additional information

• storage: store the medicine exactly as instructed by the pharmacy or healthcare facility. injectable oncology medicines are often kept under controlled conditions, protected from light if required, and handled by trained professionals. do not freeze unless the product label specifically permits it. keep out of reach of children and never use a medicine that appears discolored, contaminated, or expired.
• missed dose: because Citafine 1400mg Injection is usually administered in a clinic, missed doses are managed by the oncology team. if an appointment is missed, contact the treatment center as soon as possible. do not attempt to reschedule or self-adjust the plan without medical guidance, since timing is important in chemotherapy protocols.
• overdose: an overdose can be serious and may lead to severe bone marrow suppression, dangerous infection, bleeding, organ toxicity, or other life-threatening complications. if too much medicine is given or suspected, urgent medical attention is required immediately. treatment is supportive and may include hospital monitoring, blood tests, management of complications, and symptom-based care.
• habit forming: no. Citafine 1400mg Injection is not habit forming or addictive. it is an anticancer chemotherapy medicine used under medical supervision, and dependence is not a known effect. however, it must be used carefully because of its powerful impact on rapidly dividing cells and the need for close monitoring.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.